Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2008
04/16/2008EP0922110B1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
04/16/2008EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy
04/16/2008CN101163793A Molecular optoelectronic device and method of fabricating the same
04/16/2008CN101163715A A therapeutic agent for ass related disorders
04/16/2008CN101163714A Influenza nucleic acids, polypeptides, and uses thereof
04/16/2008CN101161817A Genes for the biosynthesis of epothilones
04/16/2008CN101161816A Plant expression carrier construction for divalent insect-resistant gene and transgenic plant acquiring method thereof
04/16/2008CN101161815A Physcomitrellapatens adversity gene Pp-cAFLP25 and encoding protein thereof, carrier and cell line containing the gene
04/16/2008CN101161814A Physcomitrellapatens adversity gene PpCor166 and encoding protein thereof, carrier and cell line containing the gene
04/16/2008CN101161813A Method for preparing human chorion gonadotrophic hormone beta subunit
04/16/2008CN101161681A Method for preparing double-flumethasone artificial antigen
04/16/2008CN101161680A Method for preparing beta-corlan artificial antigen
04/16/2008CN101161679A Method for preparing dexamethasone artificial antigen
04/16/2008CN101161678A Method for preparing diazepam artificial antigen
04/16/2008CN101161677A Recombinant polypeptide having islets beta- cell protection function
04/16/2008CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof
04/16/2008CN101161675A Rice big grain gene and uses thereof
04/16/2008CN101161284A Novel antimicrobial peptides with heparin binding activity
04/16/2008CN100381820C Method and reagent box for estimating hair growth promoting activity of object to be tested
04/16/2008CN100381570C Synovial membrane cell protein
04/16/2008CN100381565C Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant ibdv strains
04/16/2008CN100381563C Separation and purification of protein BS2 resisting cotton blight and verticillium wilt and cloning of BS2 gene
04/16/2008CN100381467C UreG protein, and its preparing method and sue
04/16/2008CN100381466C Human pifl gene, its coding protein and use thereof
04/16/2008CN100381465C Method for detecting resistance of rice bacterial leaf-blight
04/16/2008CN100381464C Multiple variants of meningococcal protein NMB1870
04/16/2008CN100381463C Immunogen for producing vaccine or medicine to treat hepatitis B, its preparation process and use
04/16/2008CN100381462C Peptides and medicinal compositions containing the same
04/16/2008CN100381170C Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use
04/16/2008CN100381168C Use of glucoprotein for pharmaceuticals
04/16/2008CA2567394A1 Glycoprotein vi antibodies and methods of use thereof
04/15/2008US7358419 Enhanced silk exsertion under stress
04/15/2008US7358418 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhamced shelf life
04/15/2008US7358417 A DNA molecule exhibiting resistance to an enhanced accumulation of lead and encoding a fungal multidrug resistance-associated protein (MRP)-like ATP-binding cassette transporter protein (MRP-like ABC transporter protein)
04/15/2008US7358416 Transgenic mouse expressing human FcRn protein
04/15/2008US7358415 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro
04/15/2008US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders
04/15/2008US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic
04/15/2008US7358351 Endothelial cell expression patterns
04/15/2008US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof
04/15/2008US7358349 Nucleic acids having expression differentials between hepatoblastoma and normal liver
04/15/2008US7358348 β-catenin nuclear localized protein
04/15/2008US7358342 Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium
04/15/2008US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders
04/15/2008US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence
04/15/2008US7358338 Heme peptide
04/15/2008US7358336 Of given sequence; used as indicators of ectopic gene expression
04/15/2008US7358334 B cell-targeted toxins for humoral immune response reduction and methods of use thereof
04/15/2008US7358333 Polypeptides of the IFNα-5 gene
04/15/2008US7358332 Bioactive peptides, uses thereof and process for the production of same
04/15/2008US7358331 Truncated fragments of alpha-synuclein in Lewy body disease
04/15/2008US7358329 Antagonists to chaperonin 10
04/15/2008US7358234 Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein
04/15/2008US7358230 Comprises antiproliferative peptides and/or polypeptides for treating tumors
04/15/2008US7358228 Methods of treating pain using neurotrophic factors
04/15/2008US7358227 Synergistic mixture of at least two recombinant bone morphogenetic protein monomers generated by contacting said the monomers with urea to prevent dimerization; slow release biodegradable glycolic acid-lactic acid copolymer
04/15/2008US7358225 G-protein-coupled receptor proteins characterized by having sufficient binding affinity for corticotropin releasing factor(CRF) such that concentrations of # 10 nM of CRF occupy 350% of the binding sites of said receptor protein
04/15/2008US7358224 Class III SLRP agonists for the reduction of blood vessel formation
04/15/2008US7358088 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer)
04/15/2008US7358087 Adjuvant for enhancing immune response to preferential immunogen
04/15/2008US7358085 Anti-angiogenic methods and compositions
04/15/2008US7358084 Enhanced secretion of a polypeptide by a microorganism
04/15/2008US7358076 Dehydroalanine-containing lantibiotic
04/15/2008US7358066 Variants and exons of the GlyT1 transporter
04/15/2008US7358061 Methods of diagnosing thyroid carcinoma
04/15/2008US7358060 Method for monitoring and prognosis of disease course of gastrointestinal tumors
04/15/2008US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease
04/15/2008US7358057 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
04/15/2008US7358053 Methods for detecting and reversing resistance to macrocyclic lactone compounds
04/15/2008US7358044 Prophylactic and therapeutic benefits of a new class of immune stimulating peptides
04/15/2008US7358041 Antibodies to magmas and uses thereof
04/15/2008US7357932 Surface protein of Neisseria bacteria
04/15/2008US7357929 Placental growth factor as a target for the treatment of osteoporosis
04/15/2008US7357928 Proteins for treatment of cancer by administering antinucleolin
04/15/2008US7357927 Death domain containing receptors
04/15/2008US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control
04/15/2008CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators
04/15/2008CA2269655C Peptide compositions with growth factor-like activity
04/15/2008CA2258740C Manufacturing process for the production of purified transferrin
04/15/2008CA2181042C Bacterial receptor structures
04/15/2008CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
04/15/2008CA2114859C Cytotoxic and antiviral compound
04/12/2008CA2563214A1 Shigella ipad protein and its use as a potential vaccine against shigella infection
04/10/2008WO2008043102A2 Vasoactive intestinal polypeptide compositions
04/10/2008WO2008042754A2 Design and construction of diverse synthetic peptide and polypeptide libraries
04/10/2008WO2008042479A2 Methods and compositions related to bacterial flagellum and nanotube formation
04/10/2008WO2008041863A1 Novel genes and polypeptides associated with insecticidal activity
04/10/2008WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use
04/10/2008WO2008041235A1 Fluorescent ruthenium compounds for detecting calcium binding proteins
04/10/2008WO2008041231A2 MEMBRANE-ANCHORED β2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
04/10/2008WO2008041106A2 Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system
04/10/2008WO2008041050A1 Malaria vaccine based on fragments and combinations of fragments of the cs protein of plasmodium vivax
04/10/2008WO2008041047A1 An artificially synthesized peptide
04/10/2008WO2008041014A2 Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer
04/10/2008WO2008040978A1 N-capped peptides with np-1 antagonist activity
04/10/2008WO2008040779A1 Thermophilic sulfate-binding protein, its use and a biosensor comprising the protein
04/10/2008WO2008040759A1 Method for down-regulation of cripto
04/10/2008WO2008040758A1 Peptides with high affinity for the prolactin receptor
04/10/2008WO2008040556A1 Dried reconstituted vesicle formation for pharmaceutical application
04/10/2008WO2008040469A1 Antibacterial and antiviral peptides from actinomadura namibiensis